Search
Search
Contact
Donate
Menu
Search
About Us
Our Vision, Mission & Values
About Clyde Campbell
Our MJFF Partnership
Our Board
Our Team
Our Ambassadors
Annual Report
Research
Our MJFF Partnership
Our Research Projects
The Shake It Up Australia Movement Disorder Capacity Building Program
Australian Parkinson’s Genetics Study
Catalyst Programme velocity (CPv)
Research Trials
How We Fund Parkinson’s Research
About PD
Symptoms of Parkinson’s
Treatments for Parkinson’s
Living with Parkinson’s
Sharing Your Diagnosis
Young Onset Parkinson’s
Genetics
Caregiver Information
Parkinson’s Stories
News
Trials
Parkinson’s Clinical Trials
Podcast
Get Involved
Fundraise
Workplace/Corporate
Fun Runs
In Memory
Contact
Donate
About Us
Our Vision, Mission & Values
About Clyde Campbell
Our MJFF Partnership
Our Board
Our Team
Our Ambassadors
Annual Report
Research
Our MJFF Partnership
Our Research Projects
The Shake It Up Australia Movement Disorder Capacity Building Program
Australian Parkinson’s Genetics Study
Catalyst Programme velocity (CPv)
Research Trials
How We Fund Parkinson’s Research
About PD
Symptoms of Parkinson’s
Treatments for Parkinson’s
Living with Parkinson’s
Sharing Your Diagnosis
Young Onset Parkinson’s
Genetics
Caregiver Information
Parkinson’s Stories
News
Trials
Parkinson’s Clinical Trials
Podcast
Get Involved
Fundraise
Workplace/Corporate
Fun Runs
In Memory
Tag:
Alpha-Synuclein
The Michael J. Fox Foundation for Parkinson’s Research Finds Parkinson’s Biomarker
Breaking News: Critical Advance Announced in Imaging the Living Parkinson’s Brain
News in Context: New Drug Approved for Alzheimer’s Disease
Potential Therapy Targeting Key Parkinson’s Protein Advances in Human Trials
The PASADENA Study – Targeting Alpha-synuclein
Understanding Alpha-Synuclein and it’s role in Parkinson’s
New Alpha-Synuclein Therapy Begins Clinical Trial
Update on Alpha-Synclein Therapies in Clinical Trials
Measuring Parkinson’s Protein Throughout Body
Important PPMI Results Highlighted in USA Today